Skip to content

VIPHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

VIPHARMA

BE 0774.494.916
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€10,208
2024 · €22,534-€12,326
Equity
€41,535
2024 · €31,327+€10,208
Cash
€63,047
2024 · €56,125+€6,922
Balance sheet total
€467,095
2024 · €471,087-€3,992

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€25,500

    down €25,500 (-14.3%), from €178,500 to €153,000

  • Receivables within one year +€12,237

    up €12,237 (+25.8%), from €47,399 to €59,636

    of which Trade receivables: +€12,652

  • Cash +€6,922

    up €6,922 (+12.3%), from €56,125 to €63,047

    mainly Depreciation (+€29,469) and Trade debts (+€22,003)

Equity and liabilities
  • Trade debts +€22,003

    up €22,003 (+102.6%), from €21,443 to €43,445

  • Debts after one year -€20,848

    down €20,848 (-16.0%), from €130,613 to €109,765

  • Other debts -€16,087

    down €16,087 (-6.2%), from €259,064 to €242,977

  • Profit (loss) carried forward +€10,208

    up €10,208 (+32.7%), from €31,227 to €41,435

Income statement
  • Gross operating margin -€7,195

    down €7,195 (-7.6%), from €94,102 to €86,908

  • Write-downs +€6,873

    new in 2025: €6,873

  • Taxes -€3,236

    down €3,236 (-52.9%), from €6,115 to €2,880

  • Financial charges +€1,411

    up €1,411 (+47.1%), from €2,997 to €4,408

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €22,534
Gross operating margin -€7,195
Staff costs -€522
Depreciation +€100
Write-downs -€6,873
Other operating charges +€339
Financial charges -€1,411
Taxes +€3,236
Result 2025 €10,208

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€27,532
Investment €0
Financing -€20,610
Cash 2024 €56,125
Net result for the year +€10,208
Depreciation +€29,469
Stocks and contracts -€4,089
Receivables within one year -€12,237
Deferred charges and accrued income -€2,229
Trade debts +€22,003
Tax, wage and social debts +€483
Other debts -€16,087
Accrued charges and deferred income +€12
Debts after one year -€20,848
Current portion of long-term debt +€238
Cash 2025 €63,047
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €471,087 €467,095 -€3,992 -0.8%
Fixed assets 21/28 €196,024 €166,556 -€29,469 -15.0%
Intangible fixed assets 21 €178,500 €153,000 -€25,500 -14.3%
Tangible fixed assets 22/27 €17,524 €13,556 -€3,969 -22.6%
Plant, machinery and equipment 23 €4,799 €3,150 -€1,649 -34.4%
Furniture and vehicles 24 €12,726 €10,406 -€2,320 -18.2%
Current assets 29/58 €275,062 €300,539 +€25,477 +9.3%
Stocks and contracts in progress 3 €168,614 €172,703 +€4,089 +2.4%
Stocks 30/36 €168,614 €172,703 +€4,089 +2.4%
Amounts receivable within one year 40/41 €47,399 €59,636 +€12,237 +25.8%
Trade receivables 40 €43,444 €56,096 +€12,652 +29.1%
Other amounts receivable 41 €3,955 €3,540 -€415 -10.5%
Cash at bank and in hand 54/58 €56,125 €63,047 +€6,922 +12.3%
Deferred charges and accrued income 490/1 €2,924 €5,153 +€2,229 +76.2%
Total equity and liabilities 10/49 €471,087 €467,095 -€3,992 -0.8%
Equity 10/15 €31,327 €41,535 +€10,208 +32.6%
Contributions 10/11 €100 €100 = 0.0%
Profit (loss) carried forward 14 €31,227 €41,435 +€10,208 +32.7%
Amounts payable 17/49 €439,760 €425,560 -€14,200 -3.2%
Amounts payable after more than one year 17 €130,613 €109,765 -€20,848 -16.0%
Financial debts 170/4 €130,613 €109,765 -€20,848 -16.0%
Amounts payable within one year 42/48 €309,147 €315,784 +€6,637 +2.1%
Current portion of amounts payable after more than one year 42 €20,610 €20,848 +€238 +1.2%
Trade debts 44 €21,443 €43,445 +€22,003 +102.6%
Suppliers 440/4 €21,443 €43,445 +€22,003 +102.6%
Taxes, remuneration and social security 45 €8,030 €8,513 +€483 +6.0%
Taxes 450/3 €212 €665 +€454 +214.5%
Remuneration and social security 454/9 €7,818 €7,847 +€30 +0.4%
Other amounts payable 47/48 €259,064 €242,977 -€16,087 -6.2%
Accrued charges and deferred income 492/3 - €12 +€12
Remuneration, social security and pensions 62 €32,456 €32,978 +€522 +1.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €29,569 €29,469 -€100 -0.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €6,873 +€6,873
Other operating charges 640/8 €431 €92 -€339 -78.7%
Gross operating margin 9900 €94,102 €86,908 -€7,195 -7.6%
Operating profit (loss) 9901 €31,646 €17,496 -€14,151 -44.7%
Financial charges 65/66B €2,997 €4,408 +€1,411 +47.1%
Recurring financial charges 65 €2,997 €4,408 +€1,411 +47.1%
Profit (loss) for the period before taxes 9903 €28,649 €13,088 -€15,562 -54.3%
Income taxes 67/77 €6,115 €2,880 -€3,236 -52.9%
Profit (loss) for the period 9904 €22,534 €10,208 -€12,326 -54.7%
Profit (loss) for the period to be appropriated 9905 €22,534 €10,208 -€12,326 -54.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.